Daiwa Securities Group
HUMA icon

Daiwa Securities Group’s Humacyte HUMA Stock Holding History

Daiwa Securities Group’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-301
Closed – – 1294
2025
Q4 		$0 Hold
301
– – ﹤0.01% 1388
2025
Q3 		$1K Hold
301
– – ﹤0.01% 1308
2025
Q2 		$1K Hold
301
– – ﹤0.01% 1264
2025
Q1 		$1K Hold
301
– – ﹤0.01% 1228
2024
Q4 		$2K Hold
301
– – ﹤0.01% 1216
2024
Q3 		$2K Hold
301
– – ﹤0.01% 1219
2024
Q2 		$1K Hold
301
– – ﹤0.01% 1291
2024
Q1 		$1K Hold
301
– – ﹤0.01% 1296
2023
Q4 		$1K Hold
301
– – ﹤0.01% 1298
2023
Q3 		$1K Hold
301
– – ﹤0.01% 1255
2023
Q2 		$1K Hold
301
– – ﹤0.01% 1276
2023
Q1 		$1K Hold
301
– – ﹤0.01% 1254
2022
Q4 		$1K Hold
301
– – ﹤0.01% 1272
2022
Q3 		$1K Hold
301
– – ﹤0.01% 1290
2022
Q2 		$1K Hold
301
– – ﹤0.01% 1291
2022
Q1 		$2K Hold
301
– – ﹤0.01% 1251
2021
Q4 		$2K Buy
+301
New +$2.98K ﹤0.01% 1284

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Daiwa Securities Group's HUMA Position: Q1 2026 in Review

Daiwa Securities Group sold out of Humacyte (HUMA) in Q1 2026, closing a stake of 301 shares.

Daiwa Securities Group first reported a position in HUMA in Q4 2021 and held it in 17 quarters. The position peaked at $2K in Q4 2024. 158 funds tracked by Wall St. Rank hold HUMA as of Q1 2026.

  • Daiwa Securities Group reported no remaining Humacyte position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 301 Humacyte shares in Q1 2026.
  • Daiwa Securities Group first reported a position in Humacyte in Q4 2021 and held it in 17 quarters.
  • Daiwa Securities Group's Humacyte position peaked at $2K in Q4 2024.
  • 158 funds tracked by Wall St. Rank held Humacyte as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.